GL
ELV icon

GLG LLC’s Elevance Health ELV Stock Holding History

GLG LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9.06M Buy
40,273
+5,000
+14% +$1.06M 0.65% 37
2017
Q3 		$6.7M Buy
35,273
+7,650
+28% +$1.46M 0.43% 62
2017
Q2 		$5.2M Buy
27,623
+2,370
+9% +$426K 0.32% 90
2017
Q1 		$4.18M Sell
25,253
-56
-0.2% -$8.91K 0.23% 131
2016
Q4 		$3.64M Buy
+25,309
New +$3.39M 0.25% 103
2016
Q2 		– Sell
-25,273
Closed -$3.51M – 493
2016
Q1 		$3.51M Sell
25,273
-4,100
-14% -$548K 0.22% 124
2015
Q4 		$4.1M Sell
29,373
-57,262
-66% -$7.89M 0.24% 111
2015
Q3 		$12.1M Buy
86,635
+49,386
+133% +$7.42M 0.3% 85
2015
Q2 		$6.11M Sell
37,249
-501
-1% -$80K 0.13% 186
2015
Q1 		$5.83M Buy
37,750
+3,149
+9% +$448K 0.17% 162
2014
Q4 		$4.35M Hold
34,601
– – 0.13% 191
2014
Q3 		$4.14M Buy
34,601
+14,526
+72% +$1.67M 0.11% 240
2014
Q2 		$2.16M Sell
20,075
-10,970
-35% -$1.13M 0.06% 351
2014
Q1 		$3.09M Buy
+31,045
New +$2.81M 0.1% 255

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GLG LLC's ELV Position: Q4 2017 in Review

GLG LLC increased its Elevance Health (ELV) stake by 14% in Q4 2017, buying an estimated $1.06M and bringing the position to 40,273 shares worth $9.06M. The position accounts for 0.65% of the portfolio, ranked #37.

GLG LLC first reported a position in ELV in Q1 2014 and has held it in 14 quarters since. The position peaked at $12.1M in Q3 2015. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • GLG LLC held 40,273 shares of Elevance Health worth $9.06M as of Q4 2017.
  • GLG LLC bought 5,000 Elevance Health shares in Q4 2017, an estimated $1.06M.
  • Elevance Health made up 0.65% of GLG LLC's portfolio in Q4 2017, its #37 holding.
  • GLG LLC first reported a position in Elevance Health in Q1 2014 and has held it in 14 quarters since.
  • GLG LLC's Elevance Health position peaked at $12.1M in Q3 2015.
  • 909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.